Hopkins Biotech Podcast
Hopkins Biotech Podcast
Illuminating life science career opportunities outside of academia through the experiences of those who have been there before.
Episodes
Roivant: Reinventing the Paradigm of Conventional Drug DevelopmentJanuary 04, 2024
Public Relations and Scientific Communications for Biotechnology with Ignacio Guerrero-RosDecember 17, 2023
What You Should Know About the Biotech Job Market in 2023 with Carina ClingmanOctober 31, 2023
Antibody-Drug Conjugates: Targeting Cancer Where it is Vulnerable with David Dornan of Elevation OncologyOctober 08, 2023
Boston Biotech Series: Standing out in the Competitive Recruiting Process for Early Stage BiotechAugust 13, 2023
Boston Biotech Series: Building a Drug Development Platform on New Biology with Isaac Klein of Dewpoint TherapeuticsJuly 16, 2023
Boston Biotech Series: Facilitating Start-up Company Formation with Adam Jenkins of BiolabsApril 17, 2023
JPM Highlights: What’s Next in ImmunoOncologyMarch 20, 2023
Lineage Cell Therapeutics: Building an Allogeneic Cell Transplant Therapy PlatformFebruary 26, 2023
JPM Highlights: Overcoming Complications in Rare Disease Drug DevelopmentFebruary 15, 2023
Adrian Rubstein: translating science to business in the Latin American biotech ecosystemJanuary 17, 2023
Cyclacel Pharmaceuticals: Interventions for Cell Cycle Abnormalities in CancerJanuary 08, 2023
Melatech: Unlocking Melanin’s Biotech Potential for the Benefit of Society in Earth and SpaceDecember 05, 2022
Ratio Therapeutics: Math Meets Medicine in the Design of RadiotherapiesNovember 20, 2022
Anupam Chakravarty: Building Community in the Graduate Education LandscapeNovember 13, 2022
Tony Russo: A Multi-Decade View of the Biotechnology IndustryOctober 30, 2022
Robert Hollingsworth: The Future of iPSC-based Cell Therapy TechnologyOctober 02, 2022
Shelley Ackerman: Immunotherapeutics Development in Graduate SchoolSeptember 04, 2022
James Coates: Company Growth Through Strategic Advising August 22, 2022
Philip Kantoff: Next Generation Radiopharmaceutical Drug DevelopmentAugust 07, 2022
Steve Doberstein: Scaling Technologies from Idea to Clinical DevelopmentJuly 25, 2022
Daniel Elgort: Data Driven Insights into the Drug Development PipelineJuly 10, 2022
Hong Tang: Targeting the Common Side Effects of Cancer TherapiesJune 30, 2022
Apprentice.io: The Future of Digitization in Pharmaceutical ProductionJune 20, 2022
Alex Harding M.D.: Business Development of Innovative Therapeutic ModalitiesMay 15, 2022